BioXcel Therapeutics, Inc. (BTAI) is up 32.91 percent, rising $0.97 to trade at $2.30 after the company announced it has regained compliance with the Nasdaq minimum closing bid price requirement.
The stock opened at $1.95 and has traded between $1.82 and $2.82 today on the Nasdaq. Trading volume has skyrocketed to 80.19 million shares, far exceeding its average of 147,006.
BioXcel's 52-week range is $1.72 to $52.80.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.